Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 06:46 am Sale | 2024-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 4,342,500 2.760% | -1,727,500 (-28.46%) | Filing History |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 13,760,200 8.700% | 5,984,440 (+76.96%) | Filing History |
| 2024-11-14 09:37 am Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Avoro Capital Advisors LLC | 12,714,874 7.900% | 12,714,874 (New Position) | Filing History |
| 2024-11-12 4:49 pm Unchanged | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 8,384,183 5.370% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 11,354,164 7.300% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:42 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 8,384,183 5.370% | 3,266,081 (+63.81%) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 11,354,164 7.300% | 5,592,631 (+97.07%) | Filing History |
| 2024-02-27 4:30 pm Purchase | 2024-02-26 | 13D | Ocular Therapeutix, Inc. OCUL | Summer Road LLC | 14,360,633 9.400% | 930,851 (+6.93%) | Filing History |
| 2024-02-14 7:48 pm Sale | 2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 6,070,000 5.510% | -5,000 (-0.08%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 5,118,102 4.460% | 1,141,249 (+28.70%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 5,761,533 5.200% | 808,796 (+16.33%) | Filing History |
| 2023-12-28 4:17 pm Purchase | 2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 7,775,760 6.800% | 7,775,760 (New Position) | Filing History |
| 2023-12-22 4:04 pm Purchase | 2023-12-14 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 9,230,769 8.380% | 9,230,769 (New Position) | Filing History |
| 2023-12-18 4:52 pm Purchase | 2023-12-14 | 13D | Ocular Therapeutix, Inc. OCUL | Summer Road LLC | 13,429,782 11.600% | 2,042,126 (+17.93%) | Filing History |
| 2023-02-13 06:11 am Purchase | 2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 6,075,000 7.890% | 100,200 (+1.68%) | Filing History |
| 2023-02-09 11:27 am Sale | 2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 3,976,853 5.160% | -102,170 (-2.50%) | Filing History |
| 2023-01-31 5:52 pm Sale | 2022-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 4,952,737 6.400% | -170,098 (-3.32%) | Filing History |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 4,079,023 5.320% | 4,079,023 (New Position) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 5,122,835 6.700% | -389,429 (-7.06%) | Filing History |
| 2022-01-31 8:38 pm Sale | 2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 5,974,800 7.800% | -535,200 (-8.22%) | Filing History |